Nanotech Acquires Financing to Ramp-Up Sales of Optical Thin Film and KolourOptik Nano-Optical Banknote Products

Nanotech Security Corp. today announced that it has completed a private placement financing of $2,655,000 million of equity units sold at $1.00 each.

A combination of institutional and accredited investors made up the majority of the offering along with approximately $175,575 sold to insiders and employees.

Commenting on the financing Doug Blakeway, CEO of Nanotech said “We were pleased with the strong interest shown in this financing which went quickly despite the tough market conditions. This financing along with our existing cash on hand provides the Company with enough working capital to ramp-up for sales opportunities for optical thin film and KolourOptik nano-optical banknote products which are now presenting themselves in greater numbers than ever.”

Each Unit consists of one common share in the capital of the Company and one-half of one common share purchase warrant. Each whole warrant will entitle the holder to purchase one common share at a price of CAD$1.50 per common share for a period of 18 months from the closing of the Offering. The warrants are subject to accelerated expiry in the event that the common shares of the Company trade on the TSX Venture Exchange at CAD$1.80 or more for a ten consecutive day period; 1) after the four month resale restricted period applicable to the Common Shares in Canada expires and 2) before the end of the initial 12 months of the term of the warrant. All securities issued in connection with the placement are subject to a hold period expiring on December 27, 2015.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.